Overview

Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine how common herpes is among persons with HIV who do not know they have it and if valacyclovir reduces outbreaks of herpes, the amount of HIV in the blood, and the amount of HSV in bodily secretions.
Phase:
N/A
Details
Lead Sponsor:
University of Alabama at Birmingham
Collaborator:
GlaxoSmithKline
Treatments:
Acyclovir
Valacyclovir